| Literature DB >> 8198388 |
Abstract
Prognostic variables such as the ejection fraction and peak oxygen consumption can be used to place patients with heart failure in risk strata. Some vasodilators have been shown to improve survival at all stages of heart failure with the probability of benefit increasing as the prognosis worsens. Quantitative estimates of survival among groups defined by prognostic variables and treatments should be used to make more informed benefit-to-risk assessments.Entities:
Mesh：
Year: 1994 PMID： 8198388 DOI： 10.1146/annurev.med.45.1.341
Source DB: PubMed Journal: Annu Rev Med ISSN： 0066-4219 Impact factor: 13.739